| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB38751-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2349-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF2349-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52586-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB3875-SP | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | NBP2-23571AF350 | |||
| Alexa Fluor 532 | NBP2-23571AF532 | |||
| Alexa Fluor 594 | NBP2-23571AF594 | |||
| Alexa Fluor 750 | NBP2-23571AF750 | |||
| DyLight 594 | NBP2-23571DL594 | |||
| PerCP | NBP2-23571PCP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-23571-0.05mg | |||
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - Mouse tissue extracts (50 ug) was separated by 10 % SDS-PAGE, and the membrane was blotted with Vitronectin antibody diluted by 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0005.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0007.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against human VTN (AA: 20-199) recombinant protein. (Expected MW is 45.9 kDa)](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Western-Blot-NBP2-52586-img0004.jpg "Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against human VTN (AA: 20-199) recombinant protein. (Expected MW is 45.9 kDa)")
![Immunohistochemistry-Paraffin: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of paraffin-embedded liver cancer tissues using VTN mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Immunohistochemistry-Paraffin-NBP2-52586-img0003.jpg)
![Flow Cytometry: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of Hela cells using VTN mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Flow-Cytometry-NBP2-52586-img0001.jpg)
![Western Blot: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis using VTN mAb against HEK293 (1) and VTN (AA: 20-199)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Western-Blot-NBP2-52586-img0005.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody (1G11E8) [NBP2-52586] - Analysis of paraffin-embedded cervical cancer tissues using VTN mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Immunohistochemistry-Paraffin-NBP2-52586-img0002.jpg)
![ELISA: Vitronectin Antibody (1G11E8) [NBP2-52586] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);](http://images.novusbio.com/fullsize/Vitronectin-Antibody-1G11E8-Flow-Cytometry-NBP2-52586-img0006.jpg)
![Immunocytochemistry/Immunofluorescence: Vitronectin Antibody [NBP2-38901] - Staining of human cell line CACO-2 shows localization to endoplasmic reticulum & vesicles.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-38901-img0003.jpg "Immunocytochemistry/Immunofluorescence: Vitronectin Antibody [NBP2-38901] - Staining of human cell line CACO-2 shows localization to endoplasmic reticulum & vesicles.")
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-38901] - Staining of human kidney shows distinct positivity in plasma.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-NBP2-38901-img0002.jpg)
![ELISA: Human Vitronectin ELISA Kit (Colorimetric) [NBP3-07095]](http://images.novusbio.com/fullsize/Human-Vitronectin-ELISA-Kit-Colorimetric-ELISA-NBP3-07095-img0001.jpg "ELISA: Human Vitronectin ELISA Kit (Colorimetric) [NBP3-07095]")
![ELISA: Human Vitronectin ELISA Kit (Colorimetric) [NBP3-07095] - Samples were spiked with high concentrations of Human Vitronectin and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp3-07095_human-vitronectin-elisa-kit-colorimetric-132202416143069.jpg)
![ELISA: Human Vitronectin ELISA Kit (Colorimetric) [NBP3-07095] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-07095_human-vitronectin-elisa-kit-colorimetric-4320249151614.jpg)